Literature DB >> 9680172

Glutathione peroxidase mimics prevent TNFalpha- and neutrophil-induced endothelial alterations.

M Moutet1, P d'Alessio, P Malette, V Devaux, J Chaudière.   

Abstract

Based on the assumption that glutathione peroxidase (GPx) activity might be limiting in preventing peroxide-induced impairment of endothelial regulatory functions, we studied the effect of a series of new selenium-containing GPx mimics on endothelial cells exposed to an inflammatory stress. The two compounds that have the highest GPx activity, BXT-51072 and BXT-51077, were shown to be the most efficient inhibitors of leukocyte recruitment by human umbilical vein endothelial cells (HUVEC), upon incubation with neutrophils (10-fold excess over HUVEC) and with 1 ng/ml TNF-alpha for 1 or 3.5 h. When HUVEC were pre- and cotreated with 10 microM of either compound, neutrophil adhesion and endothelial alteration were markedly inhibited, as assessed by immunoassays of myeloperoxidase and von Willebrand factor, respectively. These two GPx mimics were also found to be the most efficient inhibitors of the TNFalpha-induced endothelial expression of P- and E-selectin and of the TNFalpha- or interleukin1-induced endothelial release of interleukin-8. Our results demonstrate that GPx mimics such as BXT-51072 behave as potent antagonists of TNF-alpha and interleukin-1 through the downregulation of endothelial proinflammatory responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9680172     DOI: 10.1016/s0891-5849(98)00038-0

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  8 in total

Review 1.  Pharmacological antioxidant strategies as therapeutic interventions for COPD.

Authors:  Irfan Rahman
Journal:  Biochim Biophys Acta       Date:  2011-11-09

2.  Inhibition of oral midazolam clearance by boosting doses of ritonavir, and by 4,4-dimethyl-benziso-(2H)-selenazine (ALT-2074), an experimental catalytic mimic of glutathione oxidase.

Authors:  David J Greenblatt; Diane E Peters; Lauren E Oleson; Jerold S Harmatz; Malcolm W MacNab; Noah Berkowitz; Miguel A Zinny; Michael H Court
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

Review 3.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

4.  Catalase and glutathione peroxidase mimics.

Authors:  Brian J Day
Journal:  Biochem Pharmacol       Date:  2008-10-01       Impact factor: 5.858

Review 5.  The Role of Nrf2 in Cellular Innate Immune Response to Inflammatory Injury.

Authors:  Jiyoung Kim; Young-Joon Surh
Journal:  Toxicol Res       Date:  2009-12-30

6.  ROS Signaling in the Pathogenesis of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS).

Authors:  Manuela Kellner; Satish Noonepalle; Qing Lu; Anup Srivastava; Evgeny Zemskov; Stephen M Black
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

7.  Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants.

Authors:  Michael F Hill
Journal:  Curr Cardiol Rev       Date:  2008-11

8.  A Study of Selenium in Leprosy.

Authors:  Donna Partogi; Dina Arwina Dalimunthe; Cut Putri Hazlianda
Journal:  Open Access Maced J Med Sci       Date:  2018-03-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.